BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17934639)

  • 41. Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.
    Filip AA; Grenda A; Popek S; Koczkodaj D; Michalak-Wojnowska M; Budzyński M; Wąsik-Szczepanek E; Zmorzyński S; Karczmarczyk A; Giannopoulos K
    Ann Hematol; 2017 Jan; 96(1):33-50. PubMed ID: 27730344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.
    Balatti V; Rizzotto L; Miller C; Palamarchuk A; Fadda P; Pandolfo R; Rassenti LZ; Hertlein E; Ruppert AS; Lozanski A; Lozanski G; Kipps TJ; Byrd JC; Croce CM; Pekarsky Y
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2169-74. PubMed ID: 25646413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia.
    Kou Z; Mao M; Liu H; Wang X; Wang Z; Gu Z; Lang T; Nie Y; Wang Y; Huang Q; An L; Zhang X; Fu L; Li Y
    Biomark Med; 2021 Jun; 15(9):623-635. PubMed ID: 34039026
    [No Abstract]   [Full Text] [Related]  

  • 44. MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.
    Hernández-Sánchez M; Rodríguez-Vicente AE; Hernández JÁ; Lumbreras E; Sarasquete ME; Martín AÁ; Benito R; Vicente-Gutiérrez C; Robledo C; Heras Nde L; Rodríguez JN; Alcoceba M; Coca AG; Aguilar C; González M; Hernández-Rivas JM
    Leuk Res; 2016 Jul; 46():30-6. PubMed ID: 27111859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of microRNA-223 in lymphocytic leukemia cells and its action mechanism].
    Nan Z; Liang Y; Fu R; Liu H; Ruan EB; Wang XM; Wang GJ; Qu W; Liu H; Wu YH; Song J; Xing LM; Guan J; Li LJ; Wang HQ; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):556-61. PubMed ID: 23815897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The expression and prognostic significance of microRNA-34a in Uygur and Han patients with chronic lymphocytic leukemia in Xinjiang Uygur Autonomous Region in China].
    Liu H; Wang XM; Mao M; Fu L; Huang Q; Wang YL; Wang YC; Wang ZS; Li Y
    Zhonghua Nei Ke Za Zhi; 2018 Dec; 57(12):922-925. PubMed ID: 30486562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia].
    Xu L; Liang YN; Luo XQ; Liu XD; Guo HX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):178-81. PubMed ID: 21535956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
    Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
    Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
    Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
    Leuk Lymphoma; 2015; 56(11):3150-8. PubMed ID: 25860243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia.
    Rossi M; Fuligni F; Ciccone M; Agostinelli C; Righi S; Luciani M; Laginestra MA; Rigolin GM; Sapienza MR; Gazzola A; Mannu C; Cuneo A; Pileri S; Piccaluga PP
    Biomed Res Int; 2013; 2013():715391. PubMed ID: 24392455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The expression and regulatory mechanism of microRNA-708 in pediatric common B-cell acute lymphoblastic leukemia].
    Li X; Li D; Zhuang Y; Shi Q; Wei W; Zhang H; Ju XL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):138-43. PubMed ID: 23611221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies.
    Al-Harbi S; Choudhary GS; Ebron JS; Hill BT; Vivekanathan N; Ting AH; Radivoyevitch T; Smith MR; Shukla GC; Almasan A
    Mol Cancer; 2015 Nov; 14():185. PubMed ID: 26537004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.
    Ultimo S; Martelli AM; Zauli G; Vitale M; Calin GA; Neri LM
    J Cell Physiol; 2018 Aug; 233(8):5642-5654. PubMed ID: 29154447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.
    D'Abundo L; Callegari E; Bresin A; Chillemi A; Elamin BK; Guerriero P; Huang X; Saccenti E; Hussein EMAA; Casciano F; Secchiero P; Zauli G; Calin GA; Russo G; Lee LJ; Croce CM; Marcucci G; Sabbioni S; Malavasi F; Negrini M
    Oncogene; 2017 Nov; 36(47):6617-6626. PubMed ID: 28783166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.
    Patz M; Pallasch CP; Wendtner CM
    Leuk Lymphoma; 2010 Aug; 51(8):1379-81. PubMed ID: 20687796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
    Rashed WM; Hammad AM; Saad AM; Shohdy KS
    Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia.
    Luna-Aguirre CM; de la Luz Martinez-Fierro M; Mar-Aguilar F; Garza-Veloz I; Treviño-Alvarado V; Rojas-Martinez A; Jaime-Perez JC; Malagon-Santiago GI; Gutierrez-Aguirre CH; Gonzalez-Llano O; Salazar-Riojas R; Hidalgo-Miranda A; Martinez-Rodriguez HG; Gomez-Almaguer D; Ortiz-Lopez R
    Cancer Biomark; 2015; 15(3):299-310. PubMed ID: 26406572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
    Van Roosbroeck K; Calin GA
    Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.
    Wang-Renault SF; Boudaoud S; Nocturne G; Roche E; Sigrist N; Daviaud C; Bugge Tinggaard A; Renault V; Deleuze JF; Mariette X; Tost J
    Ann Rheum Dis; 2018 Jan; 77(1):133-140. PubMed ID: 28916716
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients.
    Raeisi F; Mahmoudi E; Dehghani-Samani M; Hosseini SSE; Ghahfarrokhi AM; Arshi A; Forghanparast K; Ghazanfari S
    Mol Ther Oncolytics; 2020 Mar; 16():230-237. PubMed ID: 32123723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.